首页> 外文期刊>Diabetes >Function of Isolated Pancreatic Islets From Patients at Onset of Type 1 Diabetes: Insulin Secretion Can Be Restored After Some Days in a Nondiabetogenic Environment In Vitro: Results From the DiViD Study
【24h】

Function of Isolated Pancreatic Islets From Patients at Onset of Type 1 Diabetes: Insulin Secretion Can Be Restored After Some Days in a Nondiabetogenic Environment In Vitro: Results From the DiViD Study

机译:从1型糖尿病患者中分离出的胰岛的功能:在非糖尿病形成环境中几天后,胰岛素分泌可以恢复:DiViD研究的结果

获取原文
获取原文并翻译 | 示例
       

摘要

The understanding of the etiology of type 1 diabetes (T1D) remains limited. One objective of the Diabetes Virus Detection (DiViD) study was to collect pancreatic tissue from living subjects shortly after the diagnosis of T1D. Here we report the insulin secretion ability by in vitro glucose perifusion and explore the expression of insulin pathway genes in isolated islets of Langerhans from these patients. Whole-genome RNA sequencing was performed on islets from six DiViD study patients and two organ donors who died at the onset of T1D, and the findings were compared with those from three nondiabetic organ donors. All human transcripts involved in the insulin pathway were present in the islets at the onset of T1D. Glucose-induced insulin secretion was present in some patients at the onset of T1D, and a perfectly normalized biphasic insulin release was obtained after some days in a nondiabetogenic environment in vitro. This indicates that the potential for endogenous insulin production is good, which could be taken advantage of if the disease process was reversed at diagnosis.
机译:对1型糖尿病(T1D)病因的了解仍然有限。糖尿病病毒检测(DiViD)研究的目的之一是在T1D诊断后不久从活着的受试者中收集胰腺组织。在这里,我们通过体外葡萄糖灌注报告了胰岛素的分泌能力,并探讨了这些患者朗格罕氏胰岛中胰岛素途径基因的表达。对来自六名DiViD研究患者和两名在T1D发作时死亡的器官供体的胰岛进行全基因组RNA测序,并将研究结果与三位非糖尿病器官供体的胰岛进行比较。 T1D发作时,胰岛中存在所有与胰岛素途径有关的人类转录物。某些患者在T1D发作时就出现了葡萄糖诱导的胰岛素分泌,并且在体外非糖尿病环境中几天后获得了完全归一化的双相胰岛素释放。这表明内源性胰岛素产生的潜力是好的,如果在诊断时疾病过程被逆转,则可以利用。

著录项

  • 来源
    《Diabetes》 |2015年第7期|2506-2512|共7页
  • 作者单位

    Paediatric Department, Oslo University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway;

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden;

    Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden;

    Intervention Centre and Department of Surgery, Oslo University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway;

    Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway;

    Department of Endocrinology, Oslo University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway;

    Division of Paediatrics, Department of Clinical and Experimental Medicine, Linkoeping University, Linkoeping, Sweden;

    Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden;

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden;

    Paediatric Department, Oslo University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:13

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号